MX9703282A - Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso. - Google Patents

Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso.

Info

Publication number
MX9703282A
MX9703282A MX9703282A MX9703282A MX9703282A MX 9703282 A MX9703282 A MX 9703282A MX 9703282 A MX9703282 A MX 9703282A MX 9703282 A MX9703282 A MX 9703282A MX 9703282 A MX9703282 A MX 9703282A
Authority
MX
Mexico
Prior art keywords
smooth muscle
cell proliferation
inhibitors
muscle cell
carbon atoms
Prior art date
Application number
MX9703282A
Other languages
English (en)
Other versions
MXPA97003282A (es
Inventor
Sarah Tobin Allen Novak
Richard Michael Soll
John Watson Ellingboe
Thomas The Nguyen
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MXPA97003282A publication Critical patent/MXPA97003282A/es
Publication of MX9703282A publication Critical patent/MX9703282A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Esta invencion se refiere al uso de bencilglicosidos polianionicos como inhibidores de la proliferacion de las células del musculo liso y a composiciones terapéuticas para tratar enfermedades y condiciones que se caracterizan por la proliferacion excesiva del musculo liso, tal como restenosis. Los compuestos de la invencion son aquellos de la formula (I) en donde cada uno de R1, R2, R3 y R4 son independientemente, H, SO3M, o (A); y cada grupo oligosacárido contiene 1 a 3 grupos azucar, M es litio, sodio, potasio o amonio; n es 1 o 2; X es hidrogeno, halogeno, alquilo inferior que tiene de 1 a 6 átomos de carbono, o alcoxi inferior que tiene de 1 a 6 átomos de carbono; Y es carbonilo o sulfonilo; Z es alquilo que tiene de 1 a 12 átomos de carbono (a), (b), (c) o (d); y X son como se definen anteriormente, o una sal farmacéuticamente aceptable de los mismos.
MX9703282A 1994-11-07 1995-11-03 Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso. MX9703282A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/335,278 US5498775A (en) 1994-11-07 1994-11-07 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
US08335278 1994-11-07
PCT/US1995/014686 WO1996014323A1 (en) 1994-11-07 1995-11-03 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation

Publications (2)

Publication Number Publication Date
MXPA97003282A MXPA97003282A (es) 1997-08-01
MX9703282A true MX9703282A (es) 1997-08-30

Family

ID=23311066

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703282A MX9703282A (es) 1994-11-07 1995-11-03 Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso.

Country Status (18)

Country Link
US (1) US5498775A (es)
EP (1) EP0791006B1 (es)
JP (1) JPH10508606A (es)
KR (1) KR970707139A (es)
AT (1) ATE189227T1 (es)
AU (1) AU702104B2 (es)
BR (1) BR9509606A (es)
DE (1) DE69514823T2 (es)
DK (1) DK0791006T3 (es)
ES (1) ES2141395T3 (es)
FI (1) FI971935A0 (es)
GR (1) GR3032629T3 (es)
IL (1) IL115746A (es)
MX (1) MX9703282A (es)
NZ (1) NZ296828A (es)
PT (1) PT791006E (es)
WO (1) WO1996014323A1 (es)
ZA (1) ZA959444B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
ATE377418T1 (de) 1995-06-07 2007-11-15 Poniard Pharmaceuticals Inc Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
PL185372B1 (pl) * 1995-06-29 2003-04-30 Texas Biotechnology Corp Inhibitory selektyny i kompozycja farmaceutyczna
US6001159A (en) * 1995-08-31 1999-12-14 Ricoh Company, Ltd. Reversible thermosensitive coloring composition and reversible thermosensitive recording medium using the same
US5919768A (en) * 1996-06-26 1999-07-06 Texas Biotechnology Corporation Di- and trivalent small molecule selectin inhibitors
US6451767B1 (en) 1998-11-24 2002-09-17 Wyeth Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) 1998-11-24 2003-12-16 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) 1998-11-24 2001-07-10 American Home Products Corp. Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) 1998-11-24 2001-09-18 American Home Products Corp. Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) * 1998-11-24 2006-07-25 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6187755B1 (en) 1998-11-24 2001-02-13 American Home Products Corporation Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) * 1998-11-24 2006-11-07 Wyeth Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6340670B1 (en) 1998-11-24 2002-01-22 American Home Products Corporation Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU3791200A (en) * 1998-11-24 2000-06-26 American Home Products Corporation Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
EP2124948B1 (en) 2007-02-21 2017-07-26 NC bit, Inc. Compositions for treating hyperproliferative vascular disorders and cancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431636A (en) * 1982-05-24 1984-02-14 American Cyanamid Company Bis(4-O-polyhexaose-thio)-phenyl ureas and method of use
US4431638A (en) * 1982-10-25 1984-02-14 American Cyanamid Company Poly-cation salts of bis(or tris)[4-0-monohexose-thio]-arylene sulfate derivatives
US4435387A (en) * 1982-10-25 1984-03-06 American Cyanamid Company Poly-cation salts of bis (or tris) 4-O-polyhexose-thio-arylene sulfate derivatives
US4431637A (en) * 1982-10-25 1984-02-14 American Cyanamid Company Polycation salts of bis (or tris) [4-O-polyhexose-oxy]-arylene sulfate derivatives
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
FR2634485B1 (fr) * 1988-07-21 1992-02-28 Sanopi Glycosaminoglycanes selectivement o-acyles, leur preparation et compositions pharmaceutiques les contenant
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
JPH07500843A (ja) * 1991-11-11 1995-01-26 ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルバニア 再狭窄を抑制する方法

Also Published As

Publication number Publication date
US5498775A (en) 1996-03-12
JPH10508606A (ja) 1998-08-25
IL115746A (en) 1999-11-30
FI971935A (fi) 1997-05-06
EP0791006A2 (en) 1997-08-27
DE69514823T2 (de) 2000-10-12
ES2141395T3 (es) 2000-03-16
KR970707139A (ko) 1997-12-01
PT791006E (pt) 2000-06-30
NZ296828A (en) 1999-04-29
AU702104B2 (en) 1999-02-11
DK0791006T3 (da) 2000-04-17
IL115746A0 (en) 1996-01-19
WO1996014323A1 (en) 1996-05-17
AU4154996A (en) 1996-05-31
BR9509606A (pt) 1997-10-28
EP0791006B1 (en) 2000-01-26
ATE189227T1 (de) 2000-02-15
ZA959444B (en) 1997-08-07
FI971935A0 (fi) 1997-05-06
GR3032629T3 (en) 2000-05-31
DE69514823D1 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
MX9703282A (es) Bencilglicosidos polianionicos como inhibidores de la proliferacion de las celulas del musculo liso.
AU528275B2 (en) Imidazole derivatives
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
MX9703286A (es) Inhibidores de la proliferacion celular en musculo liso.
MX9702966A (es) Bencilglicosidos acilados como inhibidores de la proliferacion de las celulas del musculo liso.
UA49089C2 (uk) Похідні вуглеводів та фармацевтична композиція на їх основі
ES483289A1 (es) Un procedimiento para la preparacion de 1,2,3,5, tetrahidro-himidazotienopirimidin-2-onas.
AU2406700A (en) 3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl(3-(1h-indol-3-yl)-a kyl)-amines

Legal Events

Date Code Title Description
FA Abandonment or withdrawal